Join over 300 leaders, experts and scientists to discuss strategies to harness the immune system for the development of innovative therapeutics
Featuring over 40 presentations, the event brings together leading pharma, biotech and academic organisations designing innovative strategies and technologies for more effective cancer immunotherapy development
Over 300 attendees representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic and healthcare institutions developing immuno-oncology therapies and tools, with over 500 attendees present when combined with its co-located events.
Over 40 presentations and case studies focussed on the latest innovations in Immuno-Oncology therapy development, patient stratification and clinical research
15 October 2020 – Day One
16 October 2020 – Day Two
The 2020 Series again brings together a panel of prominent leaders and scientists, sharing new case studies, innovative data and industry outlook
Merck & Co.
Networking & knowledge-sharing is at the heart of what we do. Alongside the innovative programme, attendees can engage in a variety of Series features and make the most of participation in a range of virtual experiences.
*Free passes are only available to industry R&D or academia.